A--Recipient Epidemiology and Donor Evaluation Study

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATIONAL INSTITUTES OF HEALTH OLAO

Contract Value

Not provided

Codes & Classification
Solicitation Number

75N92025R00025

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Classification Code

AN11

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
The National Institutes of Health (NIH), operating under the Department of Health and Human Services, has issued an award notice for the "Recipient Epidemiology and Donor Evaluation Study (REDS) Center for Transfusion Laboratory Studies (CTLS)." This procurement, identified by number 75N92025R00025, falls under the North American Industry Classification System (NAICS) code 541715, which pertains to Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). The associated Product Service Code is AN11. The primary objective of this procurement is to support advanced research and development activities focused on transfusion medicine, specifically through the REDS CTLS initiative. The purpose of the REDS program is to enhance the safety and effectiveness of blood transfusion by conducting comprehensive epidemiological studies and donor evaluations. The scope of work likely encompasses the design, execution, and analysis of laboratory-based studies that investigate both recipient outcomes and donor characteristics, with the ultimate goal of informing best practices and policy in transfusion medicine. Key requirements for this contract include demonstrated expertise in physical, engineering, and life sciences research, with a particular emphasis on laboratory studies related to transfusion. Contractors are expected to deliver robust scientific data, analytical reports, and potentially novel methodologies that contribute to the understanding of transfusion outcomes and donor safety. The intended outcomes are to generate actionable insights that can improve transfusion protocols, enhance patient safety, and optimize donor selection and management. The contracting entity for this opportunity is the NIH Office of Logistics and Acquisition Operations (OLAO), a federal office within the NIH. The primary point of contact for this procurement is Kelli B. Malkin, who can be reached via email at [email protected]. Further details and updates regarding this notice can be accessed through the official SAM.gov opportunity page at https://sam.gov/opp/c75417d59e544381b208abc8babf7c3b/view. This is an award notice, indicating that the procurement process has concluded and a contract has been awarded. There is no information provided regarding set-aside requirements or special considerations, nor are there any attachments or additional documents associated with this notice. Contractors interested in similar future opportunities should note the NIH’s ongoing commitment to advancing research in transfusion medicine and the importance of aligning capabilities with the rigorous scientific and technical standards expected by the agency. Overall, this award underscores the NIH’s dedication to supporting high-impact research that addresses critical needs in transfusion safety and efficacy, and it highlights the importance of multidisciplinary expertise in achieving these objectives.